Steve Miller - Aug 25, 2021 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Operating Officer
Signature
/s/ Steve Miller
Stock symbol
CPRX
Transactions as of
Aug 25, 2021
Transactions value $
-$70,240
Form type
4
Date filed
8/26/2021, 04:47 PM
Previous filing
Aug 17, 2021
Next filing
Dec 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $374K +120K +17.1% $3.12* 822K Aug 25, 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$445K -80K -9.74% $5.56 742K Aug 25, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 -120K -7.87% $0.00 1.41M Aug 25, 2021 Common Stock 120K $3.12 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover exercise price of options and tax withholding requirements.
F2 Shares were sold in various lots from $5.51 to $5.61 per share. The listed sale price represents a weighted average price for the shares sold.
F3 Options vested in three annual tranches beginning on August 28, 2015.